Simplified kinetic modeling for predicting the stability of complex biotherapeutics
Abstract Stability studies are vital in biologics development, guiding formulation, packaging, and shelf life determination. Traditionally, predicting long-term stability based on short-term data has been challenging due to the complex behavior of biologics. However, recently have been demonstrated...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-07037-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849768685516881920 |
|---|---|
| author | Mitja Zidar Stefano Cucuzza Matjaž Bončina Drago Kuzman |
| author_facet | Mitja Zidar Stefano Cucuzza Matjaž Bončina Drago Kuzman |
| author_sort | Mitja Zidar |
| collection | DOAJ |
| description | Abstract Stability studies are vital in biologics development, guiding formulation, packaging, and shelf life determination. Traditionally, predicting long-term stability based on short-term data has been challenging due to the complex behavior of biologics. However, recently have been demonstrated that by using simple kinetics and the Arrhenius equation, it is possible to achieve accurate long-term stability predictions for various quality attributes, including protein aggregates. This study focuses on effective modeling of aggregate predictions for diverse protein modalities, such as IgG1, IgG2, Bispecific IgG, Fc fusion, scFv, bivalent nanobodies, and DARPins, using a first-order kinetic model. Notably, findings highlight the significance of temperature selection in stability studies, enabling the identification of dominant degradation processes. Additionally, simplicity of the first-order kinetic model enhances reliability by reducing the number of parameters and samples required. The model’s effectiveness was further validated across various protein formats, beyond IgG, emphasizing its broad applicability and reliability. Compared to linear extrapolation, the kinetic model provided more precise and accurate stability estimates, even with limited data points. These findings highlight the benefits of using kinetic modeling with optimal temperature selection to predict protein aggregate stability and other quality attributes, aiding biologics development and shelf-life determination. |
| format | Article |
| id | doaj-art-bf9ae8e5018048a69dd3191ccf8bed26 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-bf9ae8e5018048a69dd3191ccf8bed262025-08-20T03:03:42ZengNature PortfolioScientific Reports2045-23222025-07-011511810.1038/s41598-025-07037-ySimplified kinetic modeling for predicting the stability of complex biotherapeuticsMitja Zidar0Stefano Cucuzza1Matjaž Bončina2Drago Kuzman3Novartis Pharma AG, TRD Biologics & CGT, GDDNovartis Pharma AG, TRD Biologics & CGT, GDDNovartis Pharma AG, TRD Biologics & CGT, GDDNovartis Pharma AG, TRD Biologics & CGT, GDDAbstract Stability studies are vital in biologics development, guiding formulation, packaging, and shelf life determination. Traditionally, predicting long-term stability based on short-term data has been challenging due to the complex behavior of biologics. However, recently have been demonstrated that by using simple kinetics and the Arrhenius equation, it is possible to achieve accurate long-term stability predictions for various quality attributes, including protein aggregates. This study focuses on effective modeling of aggregate predictions for diverse protein modalities, such as IgG1, IgG2, Bispecific IgG, Fc fusion, scFv, bivalent nanobodies, and DARPins, using a first-order kinetic model. Notably, findings highlight the significance of temperature selection in stability studies, enabling the identification of dominant degradation processes. Additionally, simplicity of the first-order kinetic model enhances reliability by reducing the number of parameters and samples required. The model’s effectiveness was further validated across various protein formats, beyond IgG, emphasizing its broad applicability and reliability. Compared to linear extrapolation, the kinetic model provided more precise and accurate stability estimates, even with limited data points. These findings highlight the benefits of using kinetic modeling with optimal temperature selection to predict protein aggregate stability and other quality attributes, aiding biologics development and shelf-life determination.https://doi.org/10.1038/s41598-025-07037-yBiologicsKinetic modelingStability predictionsAggregation |
| spellingShingle | Mitja Zidar Stefano Cucuzza Matjaž Bončina Drago Kuzman Simplified kinetic modeling for predicting the stability of complex biotherapeutics Scientific Reports Biologics Kinetic modeling Stability predictions Aggregation |
| title | Simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| title_full | Simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| title_fullStr | Simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| title_full_unstemmed | Simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| title_short | Simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| title_sort | simplified kinetic modeling for predicting the stability of complex biotherapeutics |
| topic | Biologics Kinetic modeling Stability predictions Aggregation |
| url | https://doi.org/10.1038/s41598-025-07037-y |
| work_keys_str_mv | AT mitjazidar simplifiedkineticmodelingforpredictingthestabilityofcomplexbiotherapeutics AT stefanocucuzza simplifiedkineticmodelingforpredictingthestabilityofcomplexbiotherapeutics AT matjazboncina simplifiedkineticmodelingforpredictingthestabilityofcomplexbiotherapeutics AT dragokuzman simplifiedkineticmodelingforpredictingthestabilityofcomplexbiotherapeutics |